SBBP insider filings
Strongbridge Biopharma plc — 49 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2022-01-05. Screen SBBP transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for SBBP between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Strongbridge Biopharma plc
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2022-01-05 | 4 | CDK ASSOCIATES, L.L.C. — 10% owner CAXTON CORP — 10% owner Kovner Bruce — 10% owner | Other (J): 8,060,682 · Other (J): 2,220,000 (derivative) | EDGAR |
| 2021-10-06 | 4 | Wilhoit Scott L. — Chief Commercial Officer | Disposition to issuer (D): 109,510 · Disposition to issuer (D): 649,000 (derivative) | EDGAR |
| 2021-10-06 | 4 | Cohen Fredric J. — Chief Medical Officer | Disposition to issuer (D): 160,408 · Disposition to issuer (D): 868,818 (derivative) | EDGAR |
| 2021-10-06 | 4 | Steineger Hilde H — Director | Disposition to issuer (D): 64,258 · Disposition to issuer (D): 154,918 (derivative) | EDGAR |
| 2021-10-06 | 4 | Steen Marten — Director | Disposition to issuer (D): 64,151 · Disposition to issuer (D): 154,918 (derivative) | EDGAR |
| 2021-10-06 | 4 | Kong Garheng — Director | Disposition to issuer (D): 63,993 · Disposition to issuer (D): 154,385 (derivative) | EDGAR |
| 2021-10-06 | 4 | Kollender Richard S — President and CFO | Disposition to issuer (D): 234,229 · Disposition to issuer (D): 544,918 (derivative) | EDGAR |
| 2021-10-06 | 4 | JOHNSON JOHN — Chief Executive Officer, Director | Disposition to issuer (D): 610,092 · Disposition to issuer (D): 495,724 (derivative) | EDGAR |
| 2021-10-06 | 4 | LONG STEPHEN J — Chief Legal Officer | Disposition to issuer (D): 117,793 · Disposition to issuer (D): 714,045 (derivative) | EDGAR |
| 2021-10-06 | 4 | SHERMAN JEFFREY W — Director | Disposition to issuer (D): 64,258 · Disposition to issuer (D): 140,000 (derivative) | EDGAR |
| 2021-10-06 | 4 | GILL DAVID N — Director | Disposition to issuer (D): 78,058 | EDGAR |
| 2021-10-05 | 4 | Wilhoit Scott L. — Chief Commercial Officer | Tax withholding (F): 27,515 @ $2.06 | EDGAR |
| 2021-10-05 | 4 | Cohen Fredric J. — Chief Medical Officer | Tax withholding (F): 51,548 @ $2.06 | EDGAR |
| 2021-10-05 | 4 | Steineger Hilde H — Director | Tax withholding (F): 17,763 @ $2.06 | EDGAR |
| 2021-10-05 | 4 | Steen Marten — Director | Tax withholding (F): 17,763 @ $2.06 | EDGAR |
| 2021-10-05 | 4 | Kong Garheng — Director | Tax withholding (F): 17,763 @ $2.06 | EDGAR |
| 2021-10-05 | 4 | Kollender Richard S — President and CFO | Tax withholding (F): 64,791 @ $2.06 | EDGAR |
| 2021-10-05 | 4 | JOHNSON JOHN — Chief Executive Officer, Director | Tax withholding (F): 334,868 @ $2.06 | EDGAR |
| 2021-10-05 | 4 | LONG STEPHEN J — Chief Legal Officer | Tax withholding (F): 49,307 @ $2.06 | EDGAR |
| 2021-10-05 | 4 | SHERMAN JEFFREY W — Director | Tax withholding (F): 17,763 @ $2.06 | EDGAR |
| 2021-10-05 | 4 | GILL DAVID N — Director | Tax withholding (F): 17,763 @ $2.06 | EDGAR |
| 2021-09-08 | 4 | Kollender Richard S — President and CFO | Tax withholding (F): 17,088 @ $2.24 | EDGAR |
| 2021-07-07 | 4 | JOHNSON JOHN — Chief Executive Officer, Director | Tax withholding (F): 50,867 @ $3.08 | EDGAR |
| 2021-05-18 | 4 | Steineger Hilde H — Director | Grant/award (A): 40,000 @ $0 | EDGAR |
| 2021-05-18 | 4 | Steen Marten — Director | Grant/award (A): 40,000 @ $0 | EDGAR |
| 2021-05-18 | 4 | Steen Marten — Director | Tax withholding (F): 19,004 @ $2.35 | EDGAR |
| 2021-05-18 | 4 | Kong Garheng — Director | Grant/award (A): 40,000 @ $0 | EDGAR |
| 2021-05-18 | 4 | Kollender Richard S — President and CFO | Tax withholding (F): 11,392 @ $2.28 | EDGAR |
| 2021-05-18 | 4 | SHERMAN JEFFREY W — Director | Grant/award (A): 40,000 @ $0 | EDGAR |
| 2021-05-18 | 4 | GILL DAVID N — Director | Grant/award (A): 40,000 @ $0 | EDGAR |
| 2021-05-17 | 4 | Steineger Hilde H — Director | Tax withholding (F): 18,944 @ $2.35 | EDGAR |
| 2021-05-17 | 4 | Kong Garheng — Director | Tax withholding (F): 19,200 @ $2.35 | EDGAR |
| 2021-05-17 | 4 | SHERMAN JEFFREY W — Director | Tax withholding (F): 18,944 @ $2.35 | EDGAR |
| 2021-05-17 | 4 | GILL DAVID N — Director | Tax withholding (F): 19,075 @ $2.35 | EDGAR |
| 2021-04-09 | 4 | JOHNSON JOHN — Chief Executive Officer, Director | Tax withholding (F): 17,325 @ $2.68 | EDGAR |
| 2021-03-05 | 4 | Kollender Richard S — President and CFO | Grant/award (A): 80,000 @ $0 | EDGAR |
| 2021-02-23 | 4 | Wilhoit Scott L. — Chief Commercial Officer | Tax withholding (F): 7,121 @ $3.62 | EDGAR |
| 2021-02-23 | 4 | Lutz Robert Matthew — Chief Financial Officer | Tax withholding (F): 6,978 @ $3.62 | EDGAR |
| 2021-02-23 | 4 | Cohen Fredric J. — Chief Medical Officer | Tax withholding (F): 6,978 @ $3.62 | EDGAR |
| 2021-02-23 | 4 | LONG STEPHEN J — Chief Legal Officer | Tax withholding (F): 7,062 @ $3.62 | EDGAR |
| 2021-01-08 | 4 | Wilhoit Scott L. — Chief Commercial Officer | Grant/award (A): 113,000 @ $0 | EDGAR |
| 2021-01-08 | 4 | Lutz Robert Matthew — Chief Financial Officer | Grant/award (A): 147,500 @ $0 | EDGAR |
| 2021-01-08 | 4 | Cohen Fredric J. — Chief Medical Officer | Grant/award (A): 181,000 @ $0 | EDGAR |
| 2021-01-08 | 4 | Kollender Richard S — Chief Operating Officer | Grant/award (A): 147,500 @ $0 | EDGAR |
| 2021-01-08 | 4 | JOHNSON JOHN — Chief Executive Officer, Director | Grant/award (A): 491,000 @ $0 | EDGAR |
| 2021-01-08 | 4 | LONG STEPHEN J — Chief Legal Officer | Grant/award (A): 143,500 @ $0 | EDGAR |
| 2020-09-28 | 4 | GILL DAVID N — Director | Purchase (P): 8,000 @ $2.13 | EDGAR |
| 2020-09-21 | 4 | CDK ASSOCIATES, L.L.C. — 10% owner CAXTON CORP — 10% owner Kovner Bruce — 10% owner | Purchase (P): 1,473,377 @ $2.25 · Purchase (P): 6,000 @ $2.20 | EDGAR |
| 2020-09-04 | 4 | GILL DAVID N — Director | Tax withholding (F): 23,104 @ $3.61 | EDGAR |
Recent 8-K events — Strongbridge Biopharma plc
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2021-10-05 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-09-08 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-08-30 | 8-K | 8.01 — Other Events | EDGAR |
| 2021-08-05 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-07-26 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-07-07 | 8-K | 8.01 — Other Events | EDGAR |
| 2021-05-24 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-05-14 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2021-05-13 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-05-12 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=SBBP returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs